Fundz

Obsidian Therapeutics Appoints Dana Alexander as Chief Technical Officer

RECENTLY ACQUIREDMay 08, 2024

Position

Chief Technical Officer

Company

Obsidian Therapeutics

Dana Alexander
dalexander@obsidiantx.com
CambridgeBiotechnologyHealth Care

Description

Obsidian Therapeutics, Inc. announced the appointment of Dana Alexander as Chief Technical Officer. With over two decades of operational expertise in cell therapy, gene therapy, and biologics process development, Mr

Quick answer

Obsidian Therapeutics Appoints Dana Alexander as Chief Technical Officer (May 8, 2024). Obsidian Therapeutics is based in Cambridge, Massachusetts, United States.

Who is the new Chief Technical Officer at Obsidian Therapeutics?
Obsidian Therapeutics named Dana Alexander Chief Technical Officer, announced May 8, 2024.
What did Obsidian Therapeutics announce on May 8, 2024?
Obsidian Therapeutics, Inc. announced the appointment of Dana Alexander as Chief Technical Officer.
What does Obsidian Therapeutics do?
Obsidian Therapeutics, Inc. is a clinical biotechnology company pioneering engineered cell and gene therapies to deliver transformative outcomes for patients with intractable diseases.
Where is Obsidian Therapeutics based?
Obsidian Therapeutics is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
AdvanCell (May 8, 2024), Azenta (May 8, 2024), Anika Therapeutics (May 8, 2024) and Nevro (May 7, 2024) also announced leadership changes within 45 days of Obsidian Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Obsidian Therapeutics, and when

A new leader at Obsidian Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Obsidian Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Obsidian Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Obsidian Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Obsidian Therapeutics

Location

1030 Massachusetts Avenue, Suite 400

Cambridge, Massachusetts, United States

About

Obsidian Therapeutics, Inc. is a clinical biotechnology company pioneering engineered cell and gene therapies to deliver transformative outcomes for patients with intractable diseases. Obsidian’s proprietary cytoDRiVE® technology provides a way to precisely control the timing and level of protein function by using FDA approved small molecules. Obsidian is headquartered in Cambridge, Mass. The Company has collaborations with Bristol Myers Squibb and Vertex Pharmaceuticals. For more information, please visit www.obsidiantx.com and follow us on LinkedIn and Twitter.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Obsidian Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Madan
Likely contact at this company
••••••••@••••••••

See Madan's verified email →

Alex
Likely contact at this company
••••••••@••••••••

See Alex's verified email →

Todd
Senior decision-maker at this company
••••••••@••••••••

See Todd's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Obsidian Therapeutics's next move

Learn about Strategic plan

Obsidian Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.